Do you have the same question? Follow this Question
Feb 02, 2026 - 01:09 PM
We’ve provided several answers to questions related to Keytruda (Pembrolizumab) , see some other helpful Q&A related to this product.
Question: Should patients with multiple myeloma take this medication in combination with other drugs?
Answer: Patients with multiple myeloma should not receive this medication with a thalidomide analogue and dexamethasone unless they are in controlled clinical trials. This helps prevent unsafe drug interactions and serious side effects.
Question: What are the inactive ingredients in this medication?
Answer: The inactive ingredients include L-histidine, polysorbate 80, sucrose, and Water for Injection. These components help stabilize the drug and ensure it can be safely administered by intravenous infusion, which is important for the effectiveness and safety of the therapy.
